혈관내피세포성장인자 억제제에 의한 구강편평상피세포암종 세포주의 성장 억제 효과

키워드

참고문헌 (62)

1. Kerbel RS, "Tumor angiogenesis: past, present and the nearfuture", Carcinogenesis, 21, pp.505~515 (2000)
2. Ferrara N, "Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells", Biochem Biophys Res Commun, 161, pp.851~858 (1989)
3. Maglione D, "Isolation of a human placenta cDNA coding for a protein related to the vascular perme ability factor", Proc Natl Acad Sci USA, 88, pp.9267~9271 (1991)
4. Maglione D, "Two alternative mRNAs coding for the angiogenic factor, placenta growth factor (PlGF), are transcribed from a single gene of chromosome 14", Oncogene, 8, pp.925~931 (1993)
5. Olofsson B, "Vascular endothelial growth factor B, a novel growth factor for endothelial cells", Proc Natl Acad Sci USA, 92, pp.2576~2581 (1996)
6. Joukov V, "A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4(VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases", EMBO J, 15, pp.1751~1758 (1996)
7. Lee J, "Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4", Proc Natl Acad Sci USA, 93, pp.1899~1992 (1996)
8. Orlandini M, "Identification of a c-fosinduced gene that is related to the plateletderived growth factor", vascular endothelial growth factor family, 1996, pp.93, 11675~11680
9. Senger DR, "Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid", Science, 219, pp.983~985 (1983)
10. Dvorak HF, "Vascular permeability factor", vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis, 1995, pp.146, 1029~1039
11. Benjamin LE, "Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal", J Clin Invest, 103, pp.159~165 (1999)
12. Yancopoulos GD, "Vascular-specific growth factors and blood vessel formation", Nature, 407, pp.242~248 (2000)
13. Jain RK, "Molecular regulation of vessel maturation", Nat Med, pp.685~693 (2003)
14. Ferrara N, "Vascular endothelial growth factor as a target for anticancer therapy", Oncologist, 9(1), pp.2~10 (2004)
15. Fontanini G, "Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma", Clin Cancer Res, 3, pp.861~865 (1997)
16. Plouet J, "Characterization of the receptors for vasculotropin on bovine adrenal cortex-derived capillary endothelial cells", J Biol Chem, 265, pp.22071~22075 (1990)
17. Vaisman N, "Characterization of the receptors for vascular endothelial growth factor", J Biol Chem, 265, pp.19461~19466 (1990)
18. Jakeman LB, "Binding sites for vascular endothelial growth factor are localized on endothelial cells in adult rat tissues", J Clin Invest, 89, pp.244~253 (1992)
19. Jakeman LB, "Developmental expression of binding sites and mRNA for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis", Endocrinology, 133, pp.848~859 (1993)
20. Shen H, "Characterization of vascular permeability factor", vascular endothelial growth factor receptors on mononuclear phagocytes, 1993, pp.81, 2767~2773
21. Shibuya M, "Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase (flt) closely related to the fms family", Oncogene, 8, pp.519~527 (1990)
22. Matthews W, "A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit", Proc Natl Acad Sci USA, 88, pp.9026~9030 (1991)
23. Terman BI, "Identification of a new endothelial cell growth factor receptor tyrosine kinase", Oncogene, 6, pp.1677~1683 (1991)
24. Ruzinova MB, "Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors", Cancer Cell, 4, pp.277~289 (2003)
25. Ferrara N, "The biology of vascular endothelial growth factor", Endocr Rev, 18, pp.4~25 (1997)
26. Presta LG, "Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders", Cancer Res, 57, pp.4593~4599 (1997)
27. Kim KJ, "The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutra lizing monoclonal antibodies", Growth Factors, 7, pp.53~64 (1992)
28. Gridelli C, "New antiangiogenetic agents and non-small cell lung cancer", Crit Rev Oncol Hematol, 60, pp.76~86 (2006)
29. Hurwitz H, "Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer", N Engl J Med, 350, pp.2335~2342 (2004)
30. Kabbinavar F, "Combined analysis of efficacy; the addition of bevacizumab to f1uorouracil", leucovorin improves survival for patients with metastatic colorectal cancer, 2005, pp.23, 3706~3712
31. Iohnson DH, "Randomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small cell lung cancer", J Clin Onco1, 22, pp.2184~2191 (2004)
32. Cobleigh MA, "A phase I", Il dose-escalation trial of bevacizumab in previously treated metastatic breast cancer, 2003, pp.30, 117~124
33. Borgstrom P, "Neutralizing anti-vascular endothelial growth factor, antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo", Prostate, 35, pp.1~10 (1998)
34. Berse B, "Vascular permeability factor( vasclar endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors", Mol BioI Cell, 3, pp.211~220 (1992)
35. Folkman J, "Isolation of a tumor factor responsible for angiogenesis", J Exp Med, 133, pp.275~288 (1971)
36. Folkman J, "Angiogenic factors", Science, 234, pp.442~447 (1987)
37. Gospodarowicz D, "Structural characterization and biological functions of fibroblast growth factor", Endocr Rev, 8, pp.95~114 (1987)
38. Thomas KA, "Pure brain-derived acidic fibroblast growth factor is a potent angiogenic vascular endothelial cell mitogen with sequence homology to interleukin 1", Proc Natl Acad Sci USA, 82, pp.6409~6413 (1985)
39. Esch F, "Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF", Proc Natl Acad Sci USA, 82, pp.6507~6511 (1985)
40. Jaye M, "Human endothelial cell growth factor: cloning, nucleotide sequence, and chromosome localization", Science, 233, pp.541~545 (1986)
41. Abraham JA, "Nucleotide sequence of a bovine clone encoding the angiogenic protein, basic fibroblast growth factor", Science, 233, pp.545~548 (1986)
42. Gospodarowicz D, "Production of a corpus luteum angiogenic factor responsible for proliferation of capillaries and neovascularization of the corpus luteum", Proc Natl Acad Sci USA, 75, pp.847~851 (1978)
43. Vlodavsky I, "Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix", Proc Natl Acad Sci USA, 84, pp.2292~2296 (1987)
44. Matsuzaki K, "Monoclonal antibodies against heparin-binding growth factor II", basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis, 1989, pp.86, 9911~9915
45. Dennis PA, "Studies on the role of basic fibroblast growth factor in vivo: inability of neutralizing antibodies to block tumor growth", J Cell Physiol, 144, pp.84~98 (1990)
46. Houck KA, "The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA", Mol Endocrinol, 5, pp.1806~1814 (1991)
47. Tischer E, "The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing", J Biol Chem, 266, pp.11947~11954 (1991)
48. Tournier C, "Requirement of JNK for stressinduced activation of the cytochrome c-mediated death pathway", Science, 288, pp.870~874 (2000)
49. Rajesh V, "Expression of vascular endothelial growth factor receptors on tumor cells in head and neck aquamous cell carcinoma", Arch Otolaryn Head Neck Surg, 129, pp.882~888 (2003)
50. Volm M, "Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro", Anticancer Res, 17, pp.99~103 (1997)
51. Volm M, "Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer", Int J Cancer, 74, pp.64~68 (1997)
52. Brown LF, "Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer", Hum Pathol, 26, pp.86~91 (1995)
53. Brown LF, "Expression of vascular permeability factor(vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract", Cancer Res, 53, pp.4727~4735 (1993)
54. Suzuki K, "Expression of vascular permeability factor", vascular endothelial growth factor in human hepatocellular carcinoma, 1996, pp.56, 3004~3009
55. Uchida S, "In oesophageal squamous cell carcinoma vascular endothelial growth factor is associated with p53 mutation, advanced stage and poor prognosis", Br J Cancer, 77, pp.1704~1709 (1998)
56. Brown LF, "Increased expression of vascular permeability factor (vascular endothelial growth factor) and itsreceptors in kidney and bladder carcinomas", Am J Pathol, 143, pp.1255~1262 (1993)
57. Sowter HM, "Expression and localization of the vascular endothelial growth factor family in ovarian epithelial tumors", Lab Invest, 77, pp.607~614 (1997)
58. Kim KJ, "Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo", Nature, 362, pp.841~844 (1993)
59. Presta LG, "Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders", Cancer Res, 57, pp.4593~4599 (1997)
60. Fong TA, "SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1", KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types, 1999, pp.59, 99~106
61. Wedge SR, "ZD4190: an orally active inhibitor of vascular endothelial growth factor signaling with broad-spectrum antitumor efficacy", Cancer Res, 60, pp.970~975 (2000)
62. D. Sano, "Antitumor effect of ZD6474 on head and neck squamous cell carcinoma", Oncology Reports, 17, pp.289~295 (2007)

관련 논문AI추천